Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.52 |
| ▸ | MAOB | P27338 | 11/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.43 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.42 |
| ▸ | PGR | P06401 | 2/20 | 0.40 |
| ▸ | NPC1 | O15118 | 2/20 | 0.39 |
| ▸ | RAB9A | P51151 | 2/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | BRD4 | O60885 | 1/20 | 0.38 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.38 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.38 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12478170 | 0.88 | ALDH1A1 (0.56) | ALDH1A1KDM4EMAOBMAPTPDE4B | |
| SCHEMBL30065891 | 0.85 | ALDH1A1 (0.61) | ALDH1A1KDM4EMAOBMAPTPDE4B | |
| SCHEMBL12478774 | 0.81 | ALDH1A1 (0.72) | ALDH1A1KDM4EMAOBMAPTPDE4B | |
| SCHEMBL12478157 | 0.80 | ALDH1A1 (0.52) | ALDH1A1KDM4EMAOBMAPTPDE4B | |
| SCHEMBL12478287 | 0.80 | PTGS2 (0.42) | BRD4CREBBPPTGS1PTGS2 | |
| SCHEMBL12478284 | 0.78 | KDM4E (0.52) | ALDH1A1KDM4EMAOBMAPTPGR | |
| SCHEMBL2953559 | 0.75 | ALDH1A1 (0.56) | ALDH1A1KDM4EMAOBMAPTPDE4B | |
| SCHEMBL12478603 | 0.75 | MAOB (0.49) | ALDH1A1KDM4EMAOBMAPTPDE4B | |
| SCHEMBL3956732 | 0.74 | MAOB (0.56) | ALDH1A1KDM4EMAOBMAPTPDE4B | |
| SCHEMBL12478489 | 0.73 | ALDH1A1 (0.56) | ALDH1A1KDM4EMAOBMAPTPDE4B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2012110860-A1 | TRICYCLIC COMPOUNDS AS mPGES-1 INHIBITORS | GLENMARK PHARMACEUTICALS S.A. (CH) | 2012-08-23 | — | — | WO | disclosed |